Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Feb 2026, Mar 2026 and Jun 2026.
- Largest single sale: $1.7M (25,484 shares) of BridgeBio Pharma, Inc. on Nov 12, 2025. Filing
- Last sale before this period: Jun 26, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | Oct 26, 2021 | Jun 24, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 23, 2026, BridgeBio Pharma, Inc.: sold 2,196 shares for $151K, under a disclosed plan. 1 filing: 1
- Jun 22, 2026, BridgeBio Pharma, Inc.: sold 2,808 shares for $191K, under a disclosed plan; 3,990 shares granted; 2,808 shares acquired by exercising options. 1 filing: 1
- Mar 10, 2026, BridgeBio Pharma, Inc.: sold 8,671 shares for $624K, under a disclosed plan; 8,671 shares acquired by exercising options. 1 filing: 1
- Feb 27, 2026, BridgeBio Pharma, Inc.: sold 25,484 shares for $1.7M, under a disclosed plan; 25,484 shares acquired by exercising options. 1 filing: 1
- Nov 12, 2025, BridgeBio Pharma, Inc.: sold 25,484 shares for $1.7M, no plan disclosed; 25,484 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.